Drug Pricing Dominates Senate Hearing on HHS Nominee Azar

If confirmed as the next secretary of the Department of Health and Human Services (HHS), Alex Azar says that a top priority is to make drugs more affordable. He agreed with members of the Senate Finance Committee at his confirmation hearing January 9 that drug prices are too high, but noted th Powered by WPeMatico Continue reading Drug Pricing Dominates Senate Hearing on HHS Nominee Azar

Drug Serialization for DSCSA Compliance Benefits Everyone

A minority of pharmaceutical manufacturers are on track to meet the next big Drug Supply Chain Security Act (DSCSA) deadline just around the corner. Although the FDA has announced it will delay enforcement until 2018, beginning November 27, 2017, pharma companies are required by law to serializ Powered by WPeMatico Continue reading Drug Serialization for DSCSA Compliance Benefits Everyone

Burnout in the Knowledge Economy: Does Your Company Put Enough Value in Rest?

Productivity and rest represent two sides of a scale that continually need to be balanced. They each lose their luster when the balance is off, […] The post Burnout in the Knowledge Economy: Does Your Company Put Enough Value in Rest? appeared first on e-Learning Feeds. Powered by WPeMatico Continue reading Burnout in the Knowledge Economy: Does Your Company Put Enough Value in Rest?

The UK’s New Statutory Scheme for Pricing of Branded Medicines

With a new consultation from the UK s Department of Health proposing changes to the Statutory Scheme for Pricing of Branded Medicines essentially the back-stop to the voluntary Pharmaceutical Price Regulation Scheme (PPRS) what could this mean for negotiation of a successor to the 2014 PPRS? Powered by WPeMatico Continue reading The UK’s New Statutory Scheme for Pricing of Branded Medicines